Providing insights on target engagement in clinical drug development

February 12th, 2021

 

Target engagement is key for drug development. By developing and tailoring clinical imaging biomarkers we support understanding of how drugs work. In our case studies you can read about how we have implemented advanced imaging methods to assess target engagement of dual receptor agonists. Evidence-based insights like this enables decision-making at critical time points and minimize risk in clinical drug development.

 

Read our target engagement case studies here:

 

https://antarosmedical.com/case-studies/drug-engagement-liver-glycogen-as-a-marker-of-glucagon-signaling/

 

https://antarosmedical.com/case-studies/first-in-class-pet-tracer-for-the-glucagon-receptor/

 

Back to all news